lobbying_activities: 1957758

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1957758	ea3587aa-674c-4281-9cf3-ca45a0a64d9f	Q1	TRAVERE THERAPEUTICS	401104190	TRAVERE THERAPEUTICS	2017	first_quarter	PHA	Orphan Drug Act, Drug Quality and Security Act, drug pricing, Prescription Drug User Fee Act reauthorization, FDA issues	HOUSE OF REPRESENTATIVES,SENATE		140000	0	0	2017-04-18T17:38:39.677000-04:00